Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M-VAC vs Paclitaxel + Carboplatin in High-Risk Muscle-Invasive Bladder Cancer
NCT00003701Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Apr 1999
- Primary completion
- Aug 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, carboplatin in bladder cancer, sponsored by Eastern Cooperative Oncology Group. Started Apr 1999; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00003701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003701.